StockStory.org on MSN
Why Eli Lilly (LLY) stock is trading up today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3% in the afternoon session after the ...
StockStory.org on MSN
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...
11h
S&P500 and Nasdaq: Tech Stocks Under Selling Pressure Today as Traders Brace for CPI and Jobs Data
US stocks are mixed today as tech stocks face selling pressure and traders await CPI and jobs data that could sway sentiment ...
Novo Nordisk finds itself navigating significant operational and market headwinds. The company is intensely focused on maintaining its leadership in the obes ...
Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...
Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...
Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.
TipRanks on MSN
Bank of America says market isn’t pricing in Eli Lilly’s (LLY) weight-loss drug dominance
Orforglipron is Eli Lilly’s weight-loss pill, and Bank of America expects it to enter the market in the second half of 2026 ...
BlackRock Health Sciences Trust is a Buy for income investors, offering an 8% yield, NAV discount, and resilient healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback